Cancer stem cells in breast cancer

Ryou U. Takahashi, Fumitaka Takeshita, Tomohiro Fujiwara, Makiko Ono, Takahiro Ochiya

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

The cancer stem cell (CSC) theory is generally acknowledged as an important field of cancer research, not only as an academic matter but also as a crucial aspect of clinical practice. CSCs share a variety of biological properties with normal somatic stem cells in self-renewal, the propagation of differentiated progeny, the expression of specific cell markers and stem cell genes, and the utilization of common signaling pathways and the stem cell niche. However, CSCs differ from normal stem cells in their chemoresistance and their tumorigenic and metastatic activities. In this review, we focus on recent reports regarding the identification of CSC markers and the molecular mechanism of CSC phenotypes to understand the basic properties and molecular target of CSCs. In addition, we especially focus on the CSCs of breast cancer since the use of neoadjuvant chemotherapy can lead to the enrichment of CSCs in patients with that disease. The identification of CSC markers and an improved understanding of the molecular mechanism of CSC phenotypes should lead to progress in cancer therapy and improved prognoses for patients with cancer.

Original languageEnglish
Pages (from-to)1311-1328
Number of pages18
JournalCancers
Volume3
Issue number1
DOIs
Publication statusPublished - Mar 2011

Fingerprint

Neoplastic Stem Cells
Breast Neoplasms
Stem Cells
Stem Cell Niche
Phenotype
Neoplasms
Adult Stem Cells
Drug Therapy
Research
Genes

Keywords

  • Breast cancer
  • Cancer stem cells
  • EMT
  • MicroRNAs
  • TGF-β

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Takahashi, R. U., Takeshita, F., Fujiwara, T., Ono, M., & Ochiya, T. (2011). Cancer stem cells in breast cancer. Cancers, 3(1), 1311-1328. https://doi.org/10.3390/cancers3011311

Cancer stem cells in breast cancer. / Takahashi, Ryou U.; Takeshita, Fumitaka; Fujiwara, Tomohiro; Ono, Makiko; Ochiya, Takahiro.

In: Cancers, Vol. 3, No. 1, 03.2011, p. 1311-1328.

Research output: Contribution to journalArticle

Takahashi, RU, Takeshita, F, Fujiwara, T, Ono, M & Ochiya, T 2011, 'Cancer stem cells in breast cancer', Cancers, vol. 3, no. 1, pp. 1311-1328. https://doi.org/10.3390/cancers3011311
Takahashi RU, Takeshita F, Fujiwara T, Ono M, Ochiya T. Cancer stem cells in breast cancer. Cancers. 2011 Mar;3(1):1311-1328. https://doi.org/10.3390/cancers3011311
Takahashi, Ryou U. ; Takeshita, Fumitaka ; Fujiwara, Tomohiro ; Ono, Makiko ; Ochiya, Takahiro. / Cancer stem cells in breast cancer. In: Cancers. 2011 ; Vol. 3, No. 1. pp. 1311-1328.
@article{c9443d0b4575479e9aa26a8bc842f2cd,
title = "Cancer stem cells in breast cancer",
abstract = "The cancer stem cell (CSC) theory is generally acknowledged as an important field of cancer research, not only as an academic matter but also as a crucial aspect of clinical practice. CSCs share a variety of biological properties with normal somatic stem cells in self-renewal, the propagation of differentiated progeny, the expression of specific cell markers and stem cell genes, and the utilization of common signaling pathways and the stem cell niche. However, CSCs differ from normal stem cells in their chemoresistance and their tumorigenic and metastatic activities. In this review, we focus on recent reports regarding the identification of CSC markers and the molecular mechanism of CSC phenotypes to understand the basic properties and molecular target of CSCs. In addition, we especially focus on the CSCs of breast cancer since the use of neoadjuvant chemotherapy can lead to the enrichment of CSCs in patients with that disease. The identification of CSC markers and an improved understanding of the molecular mechanism of CSC phenotypes should lead to progress in cancer therapy and improved prognoses for patients with cancer.",
keywords = "Breast cancer, Cancer stem cells, EMT, MicroRNAs, TGF-β",
author = "Takahashi, {Ryou U.} and Fumitaka Takeshita and Tomohiro Fujiwara and Makiko Ono and Takahiro Ochiya",
year = "2011",
month = "3",
doi = "10.3390/cancers3011311",
language = "English",
volume = "3",
pages = "1311--1328",
journal = "Cancers",
issn = "2072-6694",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "1",

}

TY - JOUR

T1 - Cancer stem cells in breast cancer

AU - Takahashi, Ryou U.

AU - Takeshita, Fumitaka

AU - Fujiwara, Tomohiro

AU - Ono, Makiko

AU - Ochiya, Takahiro

PY - 2011/3

Y1 - 2011/3

N2 - The cancer stem cell (CSC) theory is generally acknowledged as an important field of cancer research, not only as an academic matter but also as a crucial aspect of clinical practice. CSCs share a variety of biological properties with normal somatic stem cells in self-renewal, the propagation of differentiated progeny, the expression of specific cell markers and stem cell genes, and the utilization of common signaling pathways and the stem cell niche. However, CSCs differ from normal stem cells in their chemoresistance and their tumorigenic and metastatic activities. In this review, we focus on recent reports regarding the identification of CSC markers and the molecular mechanism of CSC phenotypes to understand the basic properties and molecular target of CSCs. In addition, we especially focus on the CSCs of breast cancer since the use of neoadjuvant chemotherapy can lead to the enrichment of CSCs in patients with that disease. The identification of CSC markers and an improved understanding of the molecular mechanism of CSC phenotypes should lead to progress in cancer therapy and improved prognoses for patients with cancer.

AB - The cancer stem cell (CSC) theory is generally acknowledged as an important field of cancer research, not only as an academic matter but also as a crucial aspect of clinical practice. CSCs share a variety of biological properties with normal somatic stem cells in self-renewal, the propagation of differentiated progeny, the expression of specific cell markers and stem cell genes, and the utilization of common signaling pathways and the stem cell niche. However, CSCs differ from normal stem cells in their chemoresistance and their tumorigenic and metastatic activities. In this review, we focus on recent reports regarding the identification of CSC markers and the molecular mechanism of CSC phenotypes to understand the basic properties and molecular target of CSCs. In addition, we especially focus on the CSCs of breast cancer since the use of neoadjuvant chemotherapy can lead to the enrichment of CSCs in patients with that disease. The identification of CSC markers and an improved understanding of the molecular mechanism of CSC phenotypes should lead to progress in cancer therapy and improved prognoses for patients with cancer.

KW - Breast cancer

KW - Cancer stem cells

KW - EMT

KW - MicroRNAs

KW - TGF-β

UR - http://www.scopus.com/inward/record.url?scp=79953720864&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79953720864&partnerID=8YFLogxK

U2 - 10.3390/cancers3011311

DO - 10.3390/cancers3011311

M3 - Article

C2 - 24212663

AN - SCOPUS:79953720864

VL - 3

SP - 1311

EP - 1328

JO - Cancers

JF - Cancers

SN - 2072-6694

IS - 1

ER -